DoD Toxic Exposures Translational Research Partnership Award

The summary for the DoD Toxic Exposures Translational Research Partnership Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept. of the Army -- USAMRAA, which is the U.S. government agency offering this grant.

DoD Toxic Exposures Translational Research Partnership Award: Summary: The intent of the FY25 Toxic Exposures Research Program (TERP) Translational Research Partnership Award (TRPA) is to support new or existing collaborative partnerships to pursue translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies, and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science or vice versa in developing and implementing the research plan.Distinctive Features: To encourage applications that include meaningful and productive collaborations between investigators, the FY25 TERP TRPA requires partnership of the Initiating Principal Investigator (PI) with at least one, and up to two, other collaborating PIs for the completion of one overarching study. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists that will accelerate the movement of promising ideas into clinical applications.